サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434997

急性虚血性脳卒中診断市場：診断薬別、生殖細胞別、生殖細胞別2024-2030年予測

Acute Ischemic Stroke Diagnosis Market by Diagnostics (Carotid Ultrasound, Cerebral Angiography, Computed Tomography), End-Use (Hospitals, Research & Diagnostic Centers) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
急性虚血性脳卒中診断市場：診断薬別、生殖細胞別、生殖細胞別2024-2030年予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

急性虚血性脳卒中診断市場規模は2023年に19億8,000万米ドルと推計され、2024年には21億米ドルに達し、CAGR 6.15%で2030年には30億2,000万米ドルに達すると予測されます。

世界の急性虚血性脳卒中診断市場

主な市場の統計
基準年[2023］ 19億8,000万米ドル
予測年[2024］ 21億米ドル
予測年 [2030] 30億2,000万米ドル
CAGR（%） 6.15%
急性虚血性脳卒中診断 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは急性虚血性脳卒中診断市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、急性虚血性脳卒中診断市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

ー市場規模とー規模および

1-急性虚血性脳卒中診断市場の市場規模および予測は？

2-急性虚血性脳卒中診断市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-急性虚血性脳卒中診断市場における技術動向と規制の枠組みは？

4-急性虚血性脳卒中診断市場における主要ベンダーの市場シェアは？

5-急性虚血性脳卒中診断市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で急性脳卒中の症例が増加
      • 消費者の間で早期臨床診断に対する高い嗜好性
      • 神経画像診断施設の成長の加速
    • 抑制要因
      • 関連する診断機器のコストの高さ
    • 機会
      • ロボティクスとAIの統合による高度な診断
      • 高度な診断のための継続的な研究開発活動
    • 課題
      • 技術的な専門知識と実務経験の不足
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 急性虚血性脳卒中診断市場診断別

  • 頸動脈超音波検査
  • 脳血管造影
  • コンピュータ断層撮影
  • 心エコー検査
  • 心電図検査
  • 磁気共鳴画像

第7章 急性虚血性脳卒中診断市場：最終用途別

  • 病院
  • 調査および診断センター

第8章 南北アメリカの急性虚血性脳卒中診断市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の急性虚血性脳卒中診断市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの急性虚血性脳卒中診断市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • BIOTRONIK SE & Co KG
    • Boehringer Ingelheim International GmbH
    • Boston Scientific Corporation
    • Canon Medical Systems Corporation
    • F. Hoffmann-La Roche Ltd
    • Fujifilm Holdings Corporation
    • GE Healthcare Technologies Inc.
    • Genentech, Inc.
    • Hitachi, Ltd.
    • Integral Diagnostics（IDX）Group
    • Koninklijke Philips N.V.
    • Mediso Kft.
    • Medtronic PLC
    • Memorial Health
    • Neusoft Medical Systems Co., Ltd.
    • Nihon Kohden Corporation
    • Planmed Oy
    • Samsung Electronics Co. Ltd
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Shimadzu Corporation
    • Siemens Healthineers company
    • Stryker Corporation
    • Toshiba International Corporation
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
  • FIGURE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2030 (%)
  • FIGURE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CAROTID ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY ELECTROCARDIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY RESEARCH & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 102. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET LICENSE & PRICING
目次
Product Code: MRR-B16853776EC9

[193 Pages Report] The Acute Ischemic Stroke Diagnosis Market size was estimated at USD 1.98 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 6.15% to reach USD 3.02 billion by 2030.

Global Acute Ischemic Stroke Diagnosis Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.98 billion
Estimated Year [2024] USD 2.10 billion
Forecast Year [2030] USD 3.02 billion
CAGR (%) 6.15%
Acute Ischemic Stroke Diagnosis Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute Ischemic Stroke Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Ischemic Stroke Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Genentech, Inc., Hitachi, Ltd., Integral Diagnostics (IDX) Group, Koninklijke Philips N.V., Mediso Kft., Medtronic PLC, Memorial Health, Neusoft Medical Systems Co., Ltd., Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, Stryker Corporation, and Toshiba International Corporation.

Market Segmentation & Coverage

This research report categorizes the Acute Ischemic Stroke Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diagnostics
    • Carotid Ultrasound
    • Cerebral Angiography
    • Computed Tomography
    • Echocardiography
    • Electrocardiography
    • Magnetic Resonance Imaging
  • End-Use
    • Hospitals
    • Research & Diagnostic Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acute Ischemic Stroke Diagnosis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Ischemic Stroke Diagnosis Market?

3. What are the technology trends and regulatory frameworks in the Acute Ischemic Stroke Diagnosis Market?

4. What is the market share of the leading vendors in the Acute Ischemic Stroke Diagnosis Market?

5. Which modes and strategic moves are suitable for entering the Acute Ischemic Stroke Diagnosis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Acute Ischemic Stroke Diagnosis Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of acute stroke cases all over the globe
      • 5.1.1.2. High preference for early clinical diagnostics among consumers
      • 5.1.1.3. Rising growth of neurological imaging and diagnostics facilities
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost of diagnostic equipments
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of robotics and AI for advanced diagnostics
      • 5.1.3.2. Ongoing research and development activities for advanced diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of technical expertise and practical experience
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Acute Ischemic Stroke Diagnosis Market, by Diagnostics

  • 6.1. Introduction
  • 6.2. Carotid Ultrasound
  • 6.3. Cerebral Angiography
  • 6.4. Computed Tomography
  • 6.5. Echocardiography
  • 6.6. Electrocardiography
  • 6.7. Magnetic Resonance Imaging

7. Acute Ischemic Stroke Diagnosis Market, by End-Use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Research & Diagnostic Centers

8. Americas Acute Ischemic Stroke Diagnosis Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. BIOTRONIK SE & Co KG
    • 12.1.3. Boehringer Ingelheim International GmbH
    • 12.1.4. Boston Scientific Corporation
    • 12.1.5. Canon Medical Systems Corporation
    • 12.1.6. F. Hoffmann-La Roche Ltd
    • 12.1.7. Fujifilm Holdings Corporation
    • 12.1.8. GE Healthcare Technologies Inc.
    • 12.1.9. Genentech, Inc.
    • 12.1.10. Hitachi, Ltd.
    • 12.1.11. Integral Diagnostics (IDX) Group
    • 12.1.12. Koninklijke Philips N.V.
    • 12.1.13. Mediso Kft.
    • 12.1.14. Medtronic PLC
    • 12.1.15. Memorial Health
    • 12.1.16. Neusoft Medical Systems Co., Ltd.
    • 12.1.17. Nihon Kohden Corporation
    • 12.1.18. Planmed Oy
    • 12.1.19. Samsung Electronics Co. Ltd
    • 12.1.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 12.1.21. Shimadzu Corporation
    • 12.1.22. Siemens Healthineers company
    • 12.1.23. Stryker Corporation
    • 12.1.24. Toshiba International Corporation
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing